vs
Capri Holdings Ltd(CPRI)与瑞思迈(RMD)财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Capri Holdings Ltd的1.4倍($1.4B vs $1.0B),瑞思迈净利率更高(27.6% vs 11.3%,领先16.3%),瑞思迈同比增速更快(11.0% vs -18.7%),瑞思迈自由现金流更多($311.2M vs $183.0M),过去两年瑞思迈的营收复合增速更高(9.0% vs -15.2%)
卡普里控股是一家跨国时尚集团,注册于英属维尔京群岛,行政总部位于伦敦,运营办公室设在纽约。品牌由美国设计师迈克尔·高仕于1981年创立,主营服饰、鞋履、手表、手袋及其他配饰产品,截至2015年在全球拥有550余家门店,以及超过1500个店中店专柜。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业,主打可接入云端的呼吸类医疗设备,用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病,新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CPRI vs RMD — 直观对比
营收规模更大
RMD
是对方的1.4倍
$1.0B
营收增速更快
RMD
高出29.7%
-18.7%
净利率更高
RMD
高出16.3%
11.3%
自由现金流更多
RMD
多$128.2M
$183.0M
两年增速更快
RMD
近两年复合增速
-15.2%
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.0B | $1.4B |
| 净利润 | $116.0M | $392.6M |
| 毛利率 | 60.8% | 61.8% |
| 营业利润率 | 4.5% | 34.6% |
| 净利率 | 11.3% | 27.6% |
| 营收同比 | -18.7% | 11.0% |
| 净利润同比 | 121.2% | 13.9% |
| 每股收益(稀释后) | $0.96 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CPRI
RMD
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $856.0M | $1.3B | ||
| Q2 25 | $797.0M | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $878.0M | $1.2B | ||
| Q2 24 | $848.0M | $1.2B | ||
| Q1 24 | — | $1.2B |
净利润
CPRI
RMD
| Q4 25 | $116.0M | $392.6M | ||
| Q3 25 | $-28.0M | $348.5M | ||
| Q2 25 | $53.0M | $379.7M | ||
| Q1 25 | $-645.0M | $365.0M | ||
| Q4 24 | $-547.0M | $344.6M | ||
| Q3 24 | $24.0M | $311.4M | ||
| Q2 24 | $-14.0M | $292.2M | ||
| Q1 24 | — | $300.5M |
毛利率
CPRI
RMD
| Q4 25 | 60.8% | 61.8% | ||
| Q3 25 | 61.0% | 61.5% | ||
| Q2 25 | 63.0% | 60.8% | ||
| Q1 25 | 64.9% | 59.3% | ||
| Q4 24 | 63.1% | 58.6% | ||
| Q3 24 | 62.3% | 58.6% | ||
| Q2 24 | 63.1% | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率
CPRI
RMD
| Q4 25 | 4.5% | 34.6% | ||
| Q3 25 | -1.4% | 33.4% | ||
| Q2 25 | 2.0% | 33.7% | ||
| Q1 25 | -47.5% | 33.0% | ||
| Q4 24 | 2.4% | 32.5% | ||
| Q3 24 | -0.7% | 31.6% | ||
| Q2 24 | 1.3% | 31.2% | ||
| Q1 24 | — | 31.3% |
净利率
CPRI
RMD
| Q4 25 | 11.3% | 27.6% | ||
| Q3 25 | -3.3% | 26.1% | ||
| Q2 25 | 6.6% | 28.2% | ||
| Q1 25 | -39.1% | 28.3% | ||
| Q4 24 | -51.2% | 26.9% | ||
| Q3 24 | 2.7% | 25.4% | ||
| Q2 24 | -1.7% | 23.9% | ||
| Q1 24 | — | 25.1% |
每股收益(稀释后)
CPRI
RMD
| Q4 25 | $0.96 | $2.68 | ||
| Q3 25 | $-0.22 | $2.37 | ||
| Q2 25 | $0.44 | $2.58 | ||
| Q1 25 | $-5.47 | $2.48 | ||
| Q4 24 | $-4.61 | $2.34 | ||
| Q3 24 | $0.20 | $2.11 | ||
| Q2 24 | $-0.12 | $1.97 | ||
| Q1 24 | — | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $154.0M | $1.4B |
| 总债务越低越好 | $234.0M | $403.9M |
| 股东权益账面价值 | $105.0M | $6.3B |
| 总资产 | $3.3B | $8.5B |
| 负债/权益比越低杠杆越低 | 2.23× | 0.06× |
8季度趋势,按日历期对齐
现金及短期投资
CPRI
RMD
| Q4 25 | $154.0M | $1.4B | ||
| Q3 25 | $120.0M | $1.4B | ||
| Q2 25 | $129.0M | $1.2B | ||
| Q1 25 | $107.0M | $932.7M | ||
| Q4 24 | $356.0M | $521.9M | ||
| Q3 24 | $182.0M | $426.4M | ||
| Q2 24 | $213.0M | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务
CPRI
RMD
| Q4 25 | $234.0M | $403.9M | ||
| Q3 25 | $1.8B | $408.7M | ||
| Q2 25 | $1.7B | $658.4M | ||
| Q1 25 | $1.5B | $663.1M | ||
| Q4 24 | $1.5B | $662.9M | ||
| Q3 24 | $1.7B | $667.6M | ||
| Q2 24 | $1.7B | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益
CPRI
RMD
| Q4 25 | $105.0M | $6.3B | ||
| Q3 25 | $-74.0M | $6.1B | ||
| Q2 25 | $-17.0M | $6.0B | ||
| Q1 25 | $368.0M | $5.5B | ||
| Q4 24 | $1.1B | $5.3B | ||
| Q3 24 | $1.5B | $5.2B | ||
| Q2 24 | $1.6B | $4.9B | ||
| Q1 24 | — | $4.6B |
总资产
CPRI
RMD
| Q4 25 | $3.3B | $8.5B | ||
| Q3 25 | $5.6B | $8.3B | ||
| Q2 25 | $5.5B | $8.2B | ||
| Q1 25 | $5.2B | $7.6B | ||
| Q4 24 | $5.9B | $7.1B | ||
| Q3 24 | $6.8B | $7.2B | ||
| Q2 24 | $6.6B | $6.9B | ||
| Q1 24 | — | $6.8B |
负债/权益比
CPRI
RMD
| Q4 25 | 2.23× | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | 4.05× | 0.12× | ||
| Q4 24 | 1.38× | 0.13× | ||
| Q3 24 | 1.15× | 0.13× | ||
| Q2 24 | 1.08× | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $202.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $183.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 17.9% | 21.9% |
| 资本支出强度资本支出/营收 | 1.9% | 2.0% |
| 现金转化率经营现金流/净利润 | 1.74× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $-134.0M | $1.8B |
8季度趋势,按日历期对齐
经营现金流
CPRI
RMD
| Q4 25 | $202.0M | $339.7M | ||
| Q3 25 | $-52.0M | $457.3M | ||
| Q2 25 | $-8.0M | $538.8M | ||
| Q1 25 | $-161.0M | $578.7M | ||
| Q4 24 | $309.0M | $308.6M | ||
| Q3 24 | $50.0M | $325.5M | ||
| Q2 24 | $83.0M | $440.1M | ||
| Q1 24 | — | $402.0M |
自由现金流
CPRI
RMD
| Q4 25 | $183.0M | $311.2M | ||
| Q3 25 | $-65.0M | $414.4M | ||
| Q2 25 | $-21.0M | $508.2M | ||
| Q1 25 | $-231.0M | $557.9M | ||
| Q4 24 | $287.0M | $288.0M | ||
| Q3 24 | $30.0M | $307.7M | ||
| Q2 24 | $67.0M | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率
CPRI
RMD
| Q4 25 | 17.9% | 21.9% | ||
| Q3 25 | -7.6% | 31.0% | ||
| Q2 25 | -2.6% | 37.7% | ||
| Q1 25 | -14.0% | 43.2% | ||
| Q4 24 | 26.9% | 22.5% | ||
| Q3 24 | 3.4% | 25.1% | ||
| Q2 24 | 7.9% | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度
CPRI
RMD
| Q4 25 | 1.9% | 2.0% | ||
| Q3 25 | 1.5% | 3.2% | ||
| Q2 25 | 1.6% | 2.3% | ||
| Q1 25 | 4.2% | 1.6% | ||
| Q4 24 | 2.1% | 1.6% | ||
| Q3 24 | 2.3% | 1.5% | ||
| Q2 24 | 1.9% | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率
CPRI
RMD
| Q4 25 | 1.74× | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | -0.15× | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 2.08× | 1.05× | ||
| Q2 24 | — | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPRI
| Michael Kors Segment | $593.0M | 58% |
| Other | $379.0M | 37% |
| Jimmy Choo Segment | $53.0M | 5% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |